Samuel Browd

Professor of Neurological Surgery at University of Washington
Seattle, Washington, USA

Certor Sports keeps Vicis R&D in Seattle, adding 4–5 jobs as it opens 230,000 sq ft HQ in Indiana

Vicis, the Seattle-based high-tech helmet maker bought out of receivership by Innovatus Capital Partners and now owned by Certor Sports, will keep its Seattle R&D office (10 employees) and add 4–5 hires while Certor opens a 230,000 sq ft headquarters in Indiana. Vicis raised over $85 million, drew NFL investor support, but collapsed in 2019 before being acquired for under $3 million and partially restarted by former staff.

AI2 Adds Bioengineer Jenny Cronin to Incubator; Icosavax Names Bekiroglu, Russo and Two Board Members; Proprio’s CMO Browd Expands Role

AI2 hired bioengineer Jenny Cronin as a principal for its startup incubator, bringing experience from s2s Public Relations, NanoString, and a UW bioengineering Ph.D.; AI2 has incubated startups like Ozette, Modulus and MajorBoost. Seattle biotech Icosavax named Elizabeth Bekiroglu general counsel, Thomas Russo CFO, and added Heidi Kunz and Ann Veneman to its board; pediatric neurosurgeon Samuel Browd is taking partial leave from UW/Seattle Children’s to expand as CMO of surgical tech startup Proprio.

See all 9 stories, episodes and videos about Samuel Browd.

Organizations

  • University of Washington logo
    University of Washington Professor of Neurological Surgery · current
  • VICIS logo
    VICIS Executive Officer, Director 2016, Co-founder · past
  • Seattle Children's Hospital Sports Concussion Program Medical Director · past

Online